Lavoltidine is an orally active, irreversible, and potent histamine H2 receptor antagonist used to strongly inhibit gastric acid secretion and induce hypergastrinemia; it shows partial suppression of gastric acid secretion and progression to neoplasia, and inhibits gastric atrophy, hyperplasia, dysplasia, and tumor development in Helicobacter felis-infected INS-GAS mice.